Literature DB >> 20609787

Bronchial replacement with arterial allografts.

Dana M Radu1, Agathe Seguin, Patrick Bruneval, Anne Fialaire Legendre, Alain Carpentier, Emmanuel Martinod.   

Abstract

BACKGROUND: Pneumonectomy is well known for a high risk of postoperative death. The alternative, sleeve lobectomy, is sometimes technically inaccessible, and is associated with locoregional recurrence. In certain situations, the use of a bronchial substitute would allow longer bronchial resections with better security margins. Previous experiments demonstrated that aortic grafts are valuable tracheal and carinal substitutes. The present study evaluated bronchial replacement with arterial allografts.
METHODS: Fifteen female sheep underwent a left bilobectomy with replacement of the bronchus intermedius with arterial allografts: 5 received a fresh graft (group 1) and 10 received cryopreserved (group 2). A bronchial silicone stent was used to confer rigidity. Evaluation was conducted on clinical and histologic criteria at regular intervals up to 18 months.
RESULTS: There were no perioperative deaths. Atelectasis, the only early postoperative complication (n = 2), was successfully treated by fiberscopic aspiration. The late postoperative period was uneventful in 12 sheep. Complications included 1 bronchopneumonia, 1 pulmonary abscess, and 1 distortion of the bronchial stent. Fiberscopic examination revealed 3 sheep with granuloma formation. The bronchial stent was removed in 3 sheep, 1 at 9 months and 2 at 12 months, without clinical complications or stenosis of the graft. Histologic analysis showed regeneration of new bronchial tissue, comprising epithelium and cartilage.
CONCLUSIONS: This study confirmed that an arterial allograft could be a valuable bronchial substitute. The use of a bronchial substitute offers new perspectives in surgical resection of lung cancer because it would avoid pneumonectomy in some patients. Copyright 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20609787     DOI: 10.1016/j.athoracsur.2010.03.079

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

Review 1.  Current Solutions for Long-Segment Tracheal Reconstruction.

Authors:  Ahmed A Abouarab; Hany H Elsayed; Hussein Elkhayat; Ahmed Mostafa; David C Cleveland; Ahmed El Nori
Journal:  Ann Thorac Cardiovasc Surg       Date:  2017-02-23       Impact factor: 1.520

2.  Small bowel in vivo bioengineering using an aortic matrix in a porcine model.

Authors:  Elie Chouillard; Elias Chahine; Eric Allaire; Anne Filaire-Legendre; Jeanne Tran Van Nhieu; Emmanuel Martinod
Journal:  Surg Endosc       Date:  2016-02-22       Impact factor: 4.584

3.  Feasibility of Bioengineered Tracheal and Bronchial Reconstruction Using Stented Aortic Matrices.

Authors:  Emmanuel Martinod; Kader Chouahnia; Dana M Radu; Pascal Joudiou; Yurdagul Uzunhan; Morad Bensidhoum; Ana M Santos Portela; Patrice Guiraudet; Marine Peretti; Marie-Dominique Destable; Audrey Solis; Sabiha Benachi; Anne Fialaire-Legendre; Hélène Rouard; Thierry Collon; Jacques Piquet; Sylvie Leroy; Nicolas Vénissac; Joseph Santini; Christophe Tresallet; Hervé Dutau; Georges Sebbane; Yves Cohen; Sadek Beloucif; Alexandre C d'Audiffret; Hervé Petite; Dominique Valeyre; Alain Carpentier; Eric Vicaut
Journal:  JAMA       Date:  2018-06-05       Impact factor: 56.272

Review 4.  Airway transplantation: a challenge for regenerative medicine.

Authors:  Emmanuel Martinod; Agathe Seguin; Dana M Radu; Guillaume Boddaert; Kader Chouahnia; Anne Fialaire-Legendre; Hervé Dutau; Nicolas Vénissac; Charles-Hugo Marquette; Christophe Baillard; Dominique Valeyre; Alain Carpentier
Journal:  Eur J Med Res       Date:  2013-07-29       Impact factor: 2.175

Review 5.  Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century.

Authors:  J-F Stoltz; N de Isla; Y P Li; D Bensoussan; L Zhang; C Huselstein; Y Chen; V Decot; J Magdalou; N Li; L Reppel; Y He
Journal:  Stem Cells Int       Date:  2015-08-02       Impact factor: 5.443

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.